Novel mutations of the lipoprotein lipase gene associated with hypertriglyceridemia in members of type 2 diabetic pedigrees

Journal of Lipid Research

Volumn 48, Issue 8, 2007, Pages 1681-1688

  Hu, Yaomin ^a,c   Ren, Yan ^a   Luo, Robert Z ^b   Mao, Xiang ^b   Li, Xiujun ^a   Cao, Xu ^a   Guan, Lu ^a   Chen, Xiang ^a   Li, Jianwei ^a   Long, Yang ^a   Zhang, Xiangxun ^a   Tian, Haoming ^a  

^a SICHUAN UNIVERSITY   (China)

^b UNIVERSITY OF TEXAS   (United States)

^c SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Function; Molecular modeling; Mutation

Indexed keywords

FATTY ACID; LIPOPROTEIN LIPASE; TRIACYLGLYCEROL;

ADULT; ARTICLE; CARBOXY TERMINAL SEQUENCE; CATALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GENE EXPRESSION; GENE LOCATION; GENE MUTATION; HUMAN; HUMAN CELL; HYPERTRIGLYCERIDEMIA; MAJOR CLINICAL STUDY; MALE; MUTAGENESIS; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; TRIACYLGLYCEROL BLOOD LEVEL;

BASE SEQUENCE; DIABETES MELLITUS, TYPE 2; EXONS; GENETIC SCREENING; HUMANS; HYPERTRIGLYCERIDEMIA; INTRONS; LIPOPROTEIN LIPASE; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MUTATION; PEDIGREE; PROMOTER REGIONS (GENETICS); PROTEIN CONFORMATION; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 34548168917     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M600382-JLR200     Document Type: Article

References (26)

1. Krauss, R. M., and P. W. Siri. 2004. Dyslipidemia in type 2 diabetes. Med. Clin. North Am. 88: 897-909.
2. Steinmetz, A. 2003. Treatment of diabetic dyslipoproteinemia. Exp. Clin. Endocrinol. Diabetes. 111: 239-245.
3. Dunn, F. L. 1990. Hyperlipidemia in diabetes mellitus. Diabetes Metab. Rev. 6: 47-61.
4. Stern, M. P., and S. M. Haffner. 1991. Dyslipidemia in type 2 diabetes: implications for therapeutic intervention. Diabetes Care. 14: 1144-1159.
5. Haffner, S. M., M. P. Stern, H. P. Hazuda, B. D. Mitchell, J. K. Patterson, and E. Ferannini. 1989. Parental history of diabetes is associated with increased cardiovascular risk factors. Arteriosclerosis. 9: 928-933.
6. Schumacher, M. C., T. Maxwell, L. L. Wu, S. C. Hunt, R. R. Williams, and S. C. Elbein. 1992. Dyslipidemias among normoglycemic members of familial NIDDM pedigrees. Diabetes Care. 15: 1285-1289.
7. Haffner, S. M., M. P. Stern, H. P. Hazuda, B. D. Mitchell, and J. K. Patterson. 1990. Cardiovascular risk factors in confirmed prediabetic individuals: does the clock for coronary heart disease start ticking before the onset of clinical diabetes? J. Am. Med. Assoc. 263: 2893-2898.
8. Haffner, S. M., and H. Miettinen. 1997. Insulin resistance implications for type II diabetes mellitus and coronary heart disease. Am. J. Med. 103: 152-162.
9. Goldberg, U., and M. Merkel. 2001. Lipoprotein lipase: physiology, biochemistry, and molecular biology. Front. Biosci. 6: d388-d405.
10. Deeb, S., and R. Peng. 1989. Structure of the human lipoprotein lipase gene. Biochemistry. 28: 4131-4135.
11. Hide, W., L. Chan, and W. H. Li. 1992. Structure and evolution of the lipase superfamily. J. Lipid Res. 33: 167-178.
12. Olivecrona, T., O. Hernell, and T. Egelrud. 1975. Lipoprotein lipase. Adv. Exp. Med. Biol. 52: 269-279.
13. Jap, T. S., S. F. Jenq, Y. C. Wu, C. Y. Chiu, and H. M. Cheng. 2003. Mutations in the lipoprotein lipase gene as a cause of hypertriglyceridemia and pancreatitis in Taiwan. Pancreas. 27: 122-126.
14. Benlian, P., J. L. De Gennes, L. Foubert, H. Zhang, S. E. Gagne, and M. Hayden. 1996. Premature atherosclerosis in patients with familial chylomicronemia caused by mutations in the lipoprotein lipase gene. N. Engl. J. Med. 335: 848-854.
15. Razzaghi, H., C. E. Aston, R. F. Hamman, and M. I. Kamboh. 2000. Genetic screening of the lipoprotein lipase gene for mutations associated with high triglyceride/low HDL-cholesterol levels. Hum. Genet. 107: 257-267.
16. Yang, T., C. P. Pang, M. W. Tsang, C. W. Lam, P. M. Poon, L. Y. Chan, X. Q. Wu, B. Tomlinson, and L. Baum. 2003. Pathogenic mutations of the lipoprotein lipase gene in Chinese patients with hypertriglyceridemic type 2 diabetes. Hum. Mutat. 21: 453-463.
17. Alberti, K. G., and P. L. Zimmet. 1998. Definition, diagnosis and classification of diabetes mellitus and its complications. Part I. Diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation. Diabet. Med. 15: 539-553.
18. Pettersen, E. F., T. D. Goddard, C. C. Huang, G. S. Couch, D. M. Greenblatt, E. C. Meng, and T. E. Ferrin. 2004. UCSF Chimera - a visualization system for exploratory research and analysis. J. Comput. Chem. 25: 1605-1612.
19. Kobayashi, Y., T. Nakajima, and I. Inoue. 2002. Molecular modeling of the dimeric structure of human lipoprotein lipase and functional studies of the carboxyl-terminal domain. Eur. J. Biochem. 269: 4701-4710.
20. Pimstone, S. N., S. M. Clee, S. E. Gagne, L. Miao, H. Zhang, E. A. Stein, and M. R. Hayden. 1996. A frequently occurring mutation in the lipoprotein lipase gene (Asn291Ser) results in altered postprandial chylomicron triglyceride and retinyl palmitate response in normolipidemic carriers. J. Lipid Res. 37: 1675-1684.
21. Razzaghi, H., B. W. Day, R. J. McClure, and M. I. Kamboh. 2001. Structure-function analysis of D9N and N291S mutations in human lipoprotein lipase using molecular modelling. J. Mol. Graph. Model. 19: 487-490.
22. Zhang, Q., E. Cavallero, M. M. Hoffmann, J. Cavanna, A. Kay, A. Charles, S. Braschi, W. Marz, L. Perlemuter, B. Jacotot, et al. 1997. Mutations at the lipoprotein lipase gene locus in subjects with diabetes mellitus, obesity and lipemia. Clin. Sci. 93: 335-341.
23. Lookene, A., L. Zhang, M. Hultin, and G. Olivecrona. 2004. Rapid subunit exchange in dimeric lipoprotein lipase and properties of the inactive monomer. J. Biol. Chem. 279: 49964-49972.
24. Evans, V., and J. J. Kastelein. 2002. Lipoprotein lipase deficiency - rare or common? Cardiovasc. Drugs Ther. 16: 283-287.
25. van Tilbeurgh, H., A. Roussel, J. M. Lalouel, and C. Cambillau. 1994. Lipoprotein lipase. Molecular model based on the pancreatic lipase X-ray structure: consequences for heparin binding and catalysis. J. Biol. Chem. 269: 4626-4633.
26. Keiper, T., J. G. Schneider, and K. A. Duji. 2001. Novel site in lipoprotein lipase (LPL415-438) essential for substrate interaction and dimer stability. J. Lipid Res. 42: 1180-1186.